[1] |
World Health Organization Regional Office for Europe. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
[2] |
World Health Organization Regional Office for Europe. Anti-tuberculosis: drug resistance in the World(Report No 4). Geneva: World Health Organization, 2008.
|
[3] |
World Health Organization Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2015. Stockholm: World Health Organization Regional Office for Europe, 2015.
|
[4] |
Javaid A, Hasan R, Zafar A, et al. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan. Int J Tuberc Lung Dis, 2017,21(3):303-308. doi: 10.5588/ijtld.16.0444.
doi: 10.5588/ijtld.16.0444
URL
pmid: 28225340
|
[5] |
全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010 年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508.
|
[6] |
马艳, 杜建, 高微微, 等. 377例复治肺结核患者耐药的危险因素研究. 中国预防医学杂志, 2018,19(9):641-646. doi: 10.16506/j.1009-6639.2018.09.001.
|
[7] |
黄曙海, 蓝如束, 刘飞鹰, 等. 广西壮族自治区肺结核耐药性调查及复治患者耐药相关因素分析. 中国防痨杂志, 2013,35(9):711-717.
|
[8] |
World Health Organization Regional Office for Europe. Treatment of Tuberculosis: guidelines for national TB programmes. Geneva: World Health Organization, 1997.
|
[9] |
Espinal MA, Kim SJ, Suarez PG, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA, 2000,283(19):2537-2545. doi: 10.1001/jama.283.19.2537.
doi: 10.1001/jama.283.19.2537
URL
pmid: 10815117
|
[10] |
World Health Organization Regional Office for Europe. Treatment of tuberculosis. 3rd ed. Geneva: World Health Organization, 2003.
|
[11] |
Ottmani SE, Zignol M, Bencheikh N, et al. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis, 2006,10(12):1367-1372.
URL
pmid: 17167954
|
[12] |
Nakanwagi-Mukwaya A, Reid AJ, Fujiwara PI, et al. Characteristics and treatment outcomes of tuberculosis retreatment cases in three regional hospitals, Uganda. Public Health Action, 2013,3(2):149-155. doi: 10.5588/pha.12.0105.
doi: 10.5588/pha.12.0105
URL
pmid: 26393019
|
[13] |
Furin J, Gegia M, Mitnick C, et al. Eliminating the category Ⅱ retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ, 2012,90(1):63-66. doi: 10.2471/BLT.11.092320.
doi: 10.2471/BLT.11.092320
URL
pmid: 22271966
|
[14] |
Saka D, Aydoğdu M, Caliᶊir HC, et al. The treatment results of retreatment pulmonary tuberculosis patients in our clinic. Tuberk Toraks, 2011,59(2):111-119. doi: 10.5578/tt.1932.
doi: 10.5578/tt.1932
URL
pmid: 21740384
|
[15] |
Tabarsi P, Chitsaz E, Tabatabaei V, et al. Revised Category Ⅱ regimen as an alternative strategy for retreatment of Category Ⅰ regimen failure and irregular treatment cases. Am J Ther, 2011,18(5):343-349. doi: 10.1097/MJT.0b013e3181dd60ec.
doi: 10.1097/MJT.0b013e3181dd60ec
URL
|
[16] |
Pedro PD, Rizzon CF, Bassanesi SL, et al. Retreatment of tuberculosis patients in the city of Porto Alegre, Brazil: outcomes. J Bras Pneumol, 2011,37(4):504-511. doi: 10.1590/s1806-37132011000400013.
doi: 10.1590/s1806-37132011000400013
URL
pmid: 21881741
|
[17] |
中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南. 北京: 中国协和医科大学出版社, 2009: 52-70.
|
[18] |
符彩云, 符致顺. 1500例复治涂阳肺结核成因及疗效分析. 中国防痨杂志, 2000,22(2):91-92.
|
[19] |
高微微. 对复治肺结核患者的规范化治疗和个体化治疗的一点看法. 中华结核和呼吸杂志, 2004,27(2):81-83.
|
[20] |
杨国儒, 张绍坤, 王国锋, 等. 对复治肺结核患者的规范化治疗和个体化治疗的几点思考. 中华结核和呼吸杂志, 2004,27(2):78-79.
|
[21] |
戈启萍, 杜建, 姜广路, 等. 标准复治化疗方案治疗多耐药与敏感复治肺结核患者的对比研究. 中国防痨杂志, 2015,37(8):879-884. doi: 10.3969/j.issn.1000-6621.2015.08.017.
|
[22] |
范玉美, 肖和平, 梅建. 首次复治肺结核患者疗效影响因素分析. 中国感染与化疗杂志, 2007,7(3):159-163.
|
[23] |
吴哲渊, 张青, 张祖荣, 等. 上海市耐多药肺结核防治管理模式效果评价. 中国防痨杂志, 2015,37(11):1118-1125. doi: 10.3969/j.issn.1000-6621.2015.11.008.
|
[24] |
沙巍, 张青, 崔文玉, 等. 首次复治肺结核患者短程化疗新方案的临床研究. 中国防痨杂志, 2017,39(1):39-45. doi: 10.3969/j.issn.1000-6621.2017.01.011.
|
[25] |
梁爽, 韩东伟, 钟威, 等. 抗结核固定剂量复合制剂联合左氧氟沙星治疗复治涂阳肺结核患者的效果分析. 结核病与肺部健康杂志, 2019,8(2):149-152. doi: 10.3969/j.issn.2095-3755.2019.02.016.
|
[26] |
Zhang SY, Fu JY, Guo XY, et al. Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen. Infect Dis Poverty, 2020,9(1):50. doi: 10.1186/s40249-020-00660-z.
doi: 10.1186/s40249-020-00660-z
URL
pmid: 32381098
|
[27] |
杜建, 刘宇红, 李亮, 等. 复治肺结核患者采用不同化疗方案的效果评价. 中国防痨杂志, 2016,38(10):850-857. doi: 10.3969/j.issn.1000-6621.2016.10.013.
|